The FDA has approved the Abbott RealTime HCV Genotype II test, which can help doctors guide treatment by differentiating genotypes 1, 1a, 1b, 2, 3, 4 and 5 of the hepatitis C virus. The new test is intended for use in patients known to have the infection and not as a diagnostic test or a screening tool for blood, according to the FDA.
FDA OKs test that IDs hepatitis C virus genotypes
SmartBrief Job Listings for Health Care
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||